Publication:

Comparison of Two Questionnaires for Dry Eye Symptom Assessment

Loading...
Thumbnail Image

Date

2015

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier BV
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Amparo, Francisco, Debra A. Schaumberg, and Reza Dana. 2015. “Comparison of Two Questionnaires for Dry Eye Symptom Assessment.” Ophthalmology 122 (7) (July): 1498–1503. doi:10.1016/j.ophtha.2015.02.037.

Abstract

Purpose

The aim of this study was to compare patient reported symptoms of dry eye disease (DED) as assessed by the Ocular Surface Disease Index (OSDI©), a 12-item symptom frequency-based questionnaire, and the Symptom Assessment iN Dry Eye (SANDE), a 2-item frequency- and severity-based visual analog scale.

Design

Clinic-based evaluation of diagnostic test.

Participants

One hundred fourteen patients with dry eye disease.

Methods

Patients were administered the OSDI and SANDE questionnaires at baseline and follow-up visits to evaluate dry eye disease-related symptoms. The correlations between both questionnaires’ scores were evaluated using the Spearman coefficient and their clinical differences were assessed using the Bland-Altman analysis.

Main Outcome Measures

Baseline and follow-up visit OSDI and SANDE dry eye symptom scores.

Results

At the baseline visit, the OSDI and SANDE questionnaire scores significantly correlated (R = 0.64; P <0.001). Moreover, a significant correlation was found between changes in the OSDI and SANDE scores from baseline to follow-up visits (R = 0.47; P <0.001). A Bland-Altman analysis, after score normalization, revealed a difference (bias) of less than two centesimal units between the scores of the two questionnaires.

Conclusions

Data collected from the SANDE questionnaire showed a significant correlation and negligible score differences with those from the OSDI, suggesting that the SANDE visual analog scale-based questionnaire has the potential to provide clinicians with a short, quick and reliable measure for DED symptoms.

Description

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Open Access Policy Articles (OAP), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories